Maria Souli - Concepedia

Author

Maria Souli

National and Kapodistrian University of Athens ORCID

Also Known As

Irene Galani, M. Souli, Maria P. Souli, Maria Souli

Publications

773

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Harvard University University General Hospital Attikon Beth Israel Deaconess Medical Center National Technical University of Athens

About

Maria Souli is an author at National and Kapodistrian University of Athens specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	152
2	Health Sciences	3	3	81
3	Immunology	2	2	44
4	Engineering	1	1	27
5	Biomolecular Engineering	1	1	27

Maria Souli

Publications

562

Citations

H-Index

Page 1

	Year	Citations
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection Charalambos Gogos, Antigone Kotsaki, George Giannikopoulos, Critical Care	2010	135
Effects of Slime Produced by Clinical Isolates of Coagulase-Negative Staphylococci on Activities of Various Antimicrobial Agents Maria Souli, Helen Giamarellou Antimicrobial Agents and Chemotherapy	1998	106
Activities of Taurolidine In Vitro and in Experimental Enterococcal Endocarditis Carlos Torres‐Viera, C Thauvin-Eliopoulos, Maria Souli, Antimicrobial Agents and Chemotherapy	2000	79
Characterization of Vancomycin-Resistant <i>Enterococcus faecium</i> Isolates from the United States and Their Susceptibility In Vitro to Dalfopristin-Quinupristin George M. Eliopoulos, Christine Wennersten, Howard S. Gold, Antimicrobial Agents and Chemotherapy	1998	69
In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens Maria Souli, Christine Wennersten, George M. Eliopoulos International Journal of Antimicrobial Agents Health SciencesMedicineKlebsiella PneumoniaeInfectious Respiratory DiseaseRespiratory Tract Pathogens	1998	51
A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab Paraskevi C. Fragkou, Maria Souli, Maria Theochari, Drug Target Insights ImmunologyPathologyImmune CheckpointsImmunotherapyTumor Immunology	2016	31
Characterization of a Dual Cellulolytic/Xylanolytic AA9 Lytic Polysaccharide Monooxygenase from <i>Thermothelomyces thermophilus</i> and its Utilization Toward Nanocellulose Production in a Multi-Step Bioprocess Koar Chorozian, Anthi Karnaouri, Antonis Karantonis, ACS Sustainable Chemistry & Engineering BiosynthesisBiomanufacturingLytic Polysaccharide MonooxygenasesEngineeringMulti-step Bioprocess	2022	27
Effects of Antimicrobial Prophylaxis on Asymptomatic Bacteriuria and Predictors of Failure in Patients with Multiple Sclerosis Maria Souli, George Koratzanis, Clementine Karageorgiou, Journal of Chemotherapy Drug ResistanceMultiple Sclerosis PatientsHealthcare-associated InfectionAntimicrobial TherapyAsymptomatic Bacteriuria	2010	18
A Case of Organizing Pneumonia (OP) Associated with Pembrolizumab Paraskevi C. Fragkou, Maria Souli, Maria Theochari, Drug Target Insights ImmunologyPathologyImmune CheckpointsImmunotherapyTumor Immunology	2016	13
Mechanisms responsible for imipenem resistance among Pseudomonas aeruginosa clinical isolates exposed to imipenem concentrations within the mutant selection window Foula Vassilara, Irene Galani, Maria Souli, Diagnostic Microbiology and Infectious Disease Medical MicrobiologyAntimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesMutant Selection Window	2017	12

Page 1